Home  /  Resource Library  /  Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy

Study investigated the effect on undectectable minimal residual disease following treatment with immunotherapy in chronic lymphocytic leukemia.